The principal objective was to evaluate the efficacy in the vaccine compared to placebo in lowering cocaine use. Secondary objectives involved confirming vaccine immunogenicity through IgG anti-cocaine antibody ranges and analyzing the protection and tolerability of vaccination via a twenty week research and at 24 7 days comply with-up. Cocaine https://peters963gfa8.activoblog.com/profile